3 vip

3 vip

BioRestorative Therapies, Inc. ( NASDAQ:BRTX – Get Free Report ) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 153,400 shares, a growth of 129.3% from the November 30th total of 66,900 shares. Approximately 3.0% of the company’s shares are sold short. Based on an average trading volume of 47,600 shares, the days-to-cover ratio is currently 3.2 days. BioRestorative Therapies Price Performance Shares of BRTX stock opened at $1.55 on Friday. The company has a market cap of $10.73 million, a PE ratio of -1.01 and a beta of 62.52. The stock’s 50 day simple moving average is $1.52 and its two-hundred day simple moving average is $1.63. BioRestorative Therapies has a 1 year low of $1.03 and a 1 year high of $3.67. BioRestorative Therapies ( NASDAQ:BRTX – Get Free Report ) last released its earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The firm had revenue of $0.23 million for the quarter, compared to analysts’ expectations of $0.30 million. Equities research analysts expect that BioRestorative Therapies will post -1.43 EPS for the current year. About BioRestorative Therapies BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Featured Stories Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter .

Robert Braswell scores 19 to help Charlotte earn 77-63 victory over Georgia State

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC , Dec. 13, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (" BioVaxys " or the " Company ") is pleased to announce that it has closed the first tranche (the " First Tranche ") of its previously announced non-brokered private placement (the " Private Placement ") with the issuance of 2,200,000 units (the " Units ") of the Company at a price of $0.05 per Unit for aggregate gross proceeds of $110,000 . Each Unit consist of one (1) common share in the capital of the Company (each, a " Share ") and one (1) whole Share purchase warrant (each, a " Warrant "), whereby each Warrant is convertible into one additional Share at an exercise price of $0.15 until December 13, 2026 , being the date that is 24 months from the date of issue. The Company intends to use the net proceeds of the First Tranche for working capital. No finder's fees were paid in connection with the First Tranche. All securities issued pursuant to the First Tranche are subject to a statutory hold period expiring April 14, 2025 , being the date that is four months and one day from the date of issuance in accordance with applicable securities legislation In addition, the Company announces that it has entered into a debt settlement agreement with an arm's-length consultant of the Company to settle an aggregate of $500,000 in debt owed to the consultant by issuing 5,000,000 Shares at a deemed price of $0.10 per Share (the " Debt Settlement "). The board of directors of the Company has determined that it is in the best interests of the Company to settle the outstanding debt through the issuance of Shares in order to preserve the Company's cash for working capital purposes. All securities proposed to be issued pursuant to the Debt Settlement will be subject to a statutory hold period of four months from the date of issuance in accordance with applicable securities legislation. Closing of the Debt Settlement is conditional upon a number of conditions, including receipt of all applicable corporate and regulatory approvals, including the acceptance of the Canadian Securities Exchange. This news release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States . The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933 , as amended (the " U.S. Securities Act "), or any state securities laws, and may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. About BioVaxys Technology Corp. BioVaxys Technology Corp. ( www.biovaxys.com ), a company registered in British Columbia, Canada , is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPXTM immune-educating technology platform and it's HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. DPXTM is a patented antigen delivery platform that can incorporate a range of bioactive molecules to produce targeted, long-lasting immune responses enabled by various formulated components. The DPX platform facilitates antigen delivery to regional lymph nodes and has been demonstrated to induce robust and durable T cell and B cell responses in pre-clinical and clinical studies for both cancer and infectious disease. BioVaxys' common shares are listed on the Canadian Securities Exchange under the stock symbol "BIOV", on the Frankfurt Bourse (FRA: 5LB), and quoted in the US on the OTC Markets. For more information, visit www.biovaxys.com and connect with us on X and LinkedIn. ON BEHALF OF THE BOARD Signed " James Passin " James Passin , Chief Executive Officer Phone: +1 740 358 0555 Cautionary Statements Regarding Forward Looking Information This news release includes certain "forward-looking information" and "forward-looking statements" (collectively " forward-looking statements ") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein, without limitation, the statements relating to the Private Placement and the Debt Settlement, including the expected use of proceeds from the Private Placement and related issuance of the Shares for the Debt Settlement, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "estimates", "potential", "possible", and similar expressions, or statements that events, conditions, or results "will", "may", "could", or "should" occur or be achieved. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those expressed or implied in such forward-looking statements. These forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates, primarily the assumption that BioVaxys will be successful in developing and testing vaccines, that, while considered reasonable by BioVaxys, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the impact of any changes that may affect the anticipated use of proceeds from the Private Placement and the ability of the Company to obtain the necessary approvals to proceed with the Debt Settlement. BioVaxys does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by applicable securities laws. The Canadian Securities Exchange has not reviewed, approved nor disapproved the contents of this press release and does not accept responsibility for the adequacy or accuracy of this release. Logo - https://mma.prnewswire.com/media/2415135/5078410/BioVaxys_Technology_Corp_Logo.jpgMichigan Senate Loser Is Out of the Running to Be FBI DirectorReaders give their views on our front page design

Guinyard's 31 lead UT Martin over Champion Christian 123-56Banks scores 21, UNC Asheville beats Western Carolina 78-61From Health-Empowering Practices to More Eco-Smart Products, Explore the Top Trends Shaping Wellness, Beauty, Home Essentials, and Cooking for the Year Ahead LAKEWOOD, Colo. , Dec. 2, 2024 /PRNewswire/ -- Natural Grocers®, America's Nutrition Education Experts SM and the nation's largest family-operated organic and natural grocery retailer, has unveiled its highly anticipated Top Trends for 2025 . Now in its ninth year, the list highlights expert predictions on the emerging products and practices set to shape the year across four key categories: Health and Wellness , Body Care and Beauty , Food and Beverage , and those that are Ecologically Thoughtful . For the 2025 predictions, Natural Grocers' expert Nutrition Education team—including Registered Dietitians and Certified Natural Foods Chefs—joined forces with its purchasing, marketing, and analytics teams. This dynamic collaboration combined deep research, consumer insights, and trend analysis to craft a forecast that's as informed as it is exciting. "At Natural Grocers , we're always eager to see how evolving trends inspire healthier, more sustainable lifestyles," stated Raquel Isely , vice president of Marketing at Natural Grocers. "Each year we sift through evolving shopping habits and cutting-edge research to pinpoint the trends that will shape the way we live, eat, and care for ourselves in the year to come. "For 2025, we're seeing a focus on simple, yet thoughtful choices that prioritize wellness and the planet—like making blood sugar-friendly habits part of everyday life, exploring ocean-inspired body care, and embracing high-quality, globally-inspired proteins. These trends aren't just exciting—they're impactful, and some can make fabulous, practical holiday gifts! Whether it's a functional, natural skincare product geared towards men, a regenerative agriculture-friendly treat, or a product that helps kick forever chemicals out of the home, there's something meaningful for everyone on your list this season." NATURAL GROCERS' TOP TRENDS FOR 2025 Natural Grocers' Top Trends for 2025 are organized into four key categories: Health & Wellness , Body Care & Beauty , Food & Beverage , and Ecologically Thoughtful , encompassing a total of twelve trends. The expert team has included its "Try This Trend" feature, offering ideas and products for those eager to dive in and explore. For the third consecutive year, the company has also introduced a Bonus Trend—a unique highlight that connects and complements the entire lineup. The full list of trends is outlined below, with each category linked to detailed insights, product recommendations, and supporting research on the company's website. HEALTH & WELLNESS TRENDS BODY CARE & BEAUTY TRENDS FOOD & BEVERAGE TRENDS ECOLOGICALLY THOUGHTFUL TRENDS *BONUS TREND* Cultivating Biodiversity Becomes a Priority Natural Grocers will highlight these trends online and across their social media platforms throughout December. They will also be featured in the January edition of Natural Grocers' good4u Health Hotline® magazine, available in both online and print formats. ABOUT NATURAL GROCERS BY VITAMIN COTTAGE Founded in 1955, Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA-certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers' flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, clean, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers and Crew make informed health and nutrition choices. Natural Grocers is committed to its 5 Founding Principles —including its "Commitment to Community" and "Commitment to Crew". In fiscal year 2024, the Company invested more than $15 million in incremental compensation and discretionary payments for Crew. Headquartered in the Union Square neighborhood of Lakewood, CO, Natural Grocers has 168 stores in 21 states. Visit www.naturalgrocers.com for more information and store locations. View original content to download multimedia: https://www.prnewswire.com/news-releases/natural-grocers-unveils-2025s-must-know-trends-302320141.html SOURCE Natural Grocers by Vitamin Cottage, Inc.

Jimmy Carter, the 39th US president, has died at 100Principal U.S. Mega-Cap ETF (USMC) to Issue Dividend of $0.15 on December 31st

SYRACUSE, N.Y. (AP) — Jakob Blakley's 28 points helped Le Moyne defeat SUNY Delhi 106-51 on Saturday. Read this article for free: Already have an account? To continue reading, please subscribe: * SYRACUSE, N.Y. (AP) — Jakob Blakley's 28 points helped Le Moyne defeat SUNY Delhi 106-51 on Saturday. Read unlimited articles for free today: Already have an account? SYRACUSE, N.Y. (AP) — Jakob Blakley’s 28 points helped Le Moyne defeat SUNY Delhi 106-51 on Saturday. Blakley added five rebounds and three steals for the Dolphins (4-8). Robby Carmody went 5 of 7 from the field (4 for 6 from 3-point range) to add 14 points. Isaac Nyakundi shot 4 of 8 from the field and 3 for 6 from the line to finish with 11 points, while adding seven rebounds. The Broncos were led by Lester McCarthy, who recorded 16 points. Abdul-Jaleel Ibrahim added seven points. Isaiah Barnes had four points and three steals. __ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar. AdvertisementThe US says it pushed retraction of a famine warning for north Gaza. Aid groups express concern.